Minerva Neurosciences, Inc.NERVNASDAQ
Loading
Year-over-year operating cash flow growth rate
Percentile
P10
Near historical low
vs 5Y Ago
-2x
Contraction
Streak
2 qtr
Consecutive declineDecelerating
| Period | Value |
|---|---|
| Q4 2025 | -53.66% |
| Q3 2025 | -42.80% |
| Q2 2025 | 0.00% |
| Q1 2025 | 0.00% |
| Q4 2024 | -18.72% |
| Q3 2024 | -10.54% |
| Q2 2024 | 35.39% |
| Q1 2024 | -1.72% |
| Q4 2023 | -24.66% |
| Q3 2023 | -24.13% |
| Q2 2023 | -3254.98% |
| Q1 2023 | 97.19% |
| Q4 2022 | 56.89% |
| Q3 2022 | -83.60% |
| Q2 2022 | 10.60% |
| Q1 2022 | -20.18% |
| Q4 2021 | 43.98% |
| Q3 2021 | -45.60% |
| Q2 2021 | -13.56% |
| Q1 2021 | 27.12% |
| Q4 2020 | 27.48% |
| Q3 2020 | -30.08% |
| Q2 2020 | 17.53% |
| Q1 2020 | 35.11% |
| Q4 2019 | -48.94% |
| Q3 2019 | 6.01% |
| Q2 2019 | -5.51% |
| Q1 2019 | 2.03% |
| Q4 2018 | 1.85% |
| Q3 2018 | 11.05% |
| Q2 2018 | -2.69% |
| Q1 2018 | -22.67% |
| Q4 2017 | -135.80% |
| Q3 2017 | 463.72% |
| Q2 2017 | -13.23% |
| Q1 2017 | 32.29% |
| Q4 2016 | -91.73% |
| Q3 2016 | 23.10% |
| Q2 2016 | -0.09% |
| Q1 2016 | 8.38% |